NTRK1 and neoplasm: The results indicated a MSS tumor with EGFR 19del (p.L747_T751del) (VAF: 52.3%), TPR-NTRK1 fusion (VAF: 5.1%), and EGFR amplification (8.5 copies) (Table 1).